A 500mg daily dose of metformin typically lowers fasting blood sugar by about 19 to 25 mg/dL compared to a placebo, based on dose-response trial data. That’s a modest but meaningful reduction, and it’s the reason 500mg is used as a starting dose rather than the target dose for most people with type 2 diabetes.
What the Dose-Response Data Shows
The clearest evidence comes from a double-blind, placebo-controlled trial published in The American Journal of Medicine that tested metformin at doses ranging from 500mg to 2,000mg daily. Across the trial, metformin doses in that range lowered fasting blood sugar by 19 to 84 mg/dL more than placebo. The 500mg dose sat at the bottom of that range, producing the smallest reduction. In fact, by the study’s endpoint, the difference between 500mg and placebo just barely missed statistical significance (p = 0.054), meaning the effect was real but small enough that chance couldn’t be fully ruled out.
By comparison, higher doses produced progressively larger drops. Moving up to 1,000mg or 1,500mg daily roughly doubled or tripled the fasting glucose reduction. At 2,000mg daily, the full 84 mg/dL reduction was observed. This is why most prescribers start patients at 500mg and gradually increase the dose over several weeks. The 500mg starting point isn’t meant to be the final therapeutic dose for most people. It’s designed to let your body adjust and minimize side effects, particularly the digestive issues metformin is known for.
How Quickly It Starts Working
Metformin begins lowering blood sugar within the first week of treatment. Studies show rapid decreases in fasting blood sugar by the end of week one, so the effect isn’t something you wait months to notice. However, the full impact on longer-term markers like A1c takes two to three months to develop. A1c reflects your average blood sugar over roughly 90 days, so it naturally takes a full cycle of red blood cells turning over before that number catches up to your daily improvements.
Once absorbed, a standard 500mg tablet reaches its peak concentration in the blood within about four to five hours. About 90% of the absorbed drug is cleared through the kidneys within 24 hours, with a plasma half-life of around six hours. Extended-release versions of the same 500mg dose take longer to peak, closer to seven or eight hours, but spread the effect out more evenly across the day.
How Metformin Lowers Blood Sugar
Metformin’s primary target is the liver. Your liver continuously produces glucose, even when you’re not eating, through a process called gluconeogenesis. Metformin slows this process down by interfering with the energy machinery inside liver cells, specifically by inhibiting a part of the mitochondria (the cell’s power generators) called complex I. When complex I is suppressed, the liver has less energy available to manufacture new glucose, and your fasting blood sugar drops as a result.
There’s also an intestinal component. Metformin stimulates the release of a gut hormone called GLP-1, which sends a signal through the nervous system to further reduce the liver’s glucose output. This gut-brain-liver loop adds to the overall blood sugar lowering effect. Importantly, metformin doesn’t force your pancreas to produce more insulin, which is why it carries almost no risk of causing dangerously low blood sugar on its own.
500mg in Prediabetes Prevention
The landmark Diabetes Prevention Program trial showed that metformin reduced the risk of developing type 2 diabetes by 31% over three years compared to placebo. That trial used 850mg twice daily, not 500mg, so the results don’t translate directly to a lower dose. Over 21 years of follow-up, the benefit persisted but narrowed to a 17% reduction in diabetes development. Lifestyle changes (moderate weight loss and increased physical activity) outperformed metformin at both time points, reducing risk by 58% at three years and 24% at 21 years.
If you’re taking 500mg specifically for prediabetes, it’s reasonable to expect a smaller protective effect than what the DPP trial demonstrated, since the study used a higher dose. Still, even at 500mg, the drug is reducing the liver’s glucose output and improving how your body handles sugar, which works in your favor.
Why 500mg Is Usually Just the Starting Point
For most people with type 2 diabetes, 500mg daily doesn’t produce enough blood sugar reduction on its own to reach target A1c levels. The dose-response relationship with metformin is fairly linear up to about 2,000mg per day, meaning each additional 500mg increment brings additional benefit. The standard approach is to start at 500mg once or twice daily and increase by 500mg every one to two weeks as tolerated, with most people ending up on 1,500mg to 2,000mg daily.
Some people do stay on 500mg long-term, particularly if they have mild elevations in blood sugar, are using it alongside other medications, or experience side effects at higher doses. For someone with a fasting blood sugar of, say, 140 mg/dL, a 20 mg/dL drop from 500mg alone brings them closer to the normal range but likely not all the way there. Someone with a fasting level of 115 mg/dL might find that 500mg is enough to bring them under the 100 mg/dL threshold for normal fasting glucose.
The actual reduction you experience depends on your starting blood sugar level, how much glucose your liver is overproducing, your kidney function (since that’s how metformin is cleared), and whether you’re making dietary and exercise changes at the same time. People with higher starting blood sugar levels tend to see larger absolute drops, while those closer to normal see smaller but still clinically useful reductions.